Literature DB >> 20300093

Kinase inhibitors: narrowing down the real targets.

Henrik Daub.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20300093     DOI： 10.1038/nchembio.336

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN： 1552-4450            Impact factor:   15.040


× No keyword cloud information.
  10 in total

1.  Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitors.

Authors:  Stephanie Blencke; Birgit Zech; Ola Engkvist; Zoltán Greff; László Orfi; Zoltán Horváth; György Kéri; Axel Ullrich; Henrik Daub
Journal:  Chem Biol       Date:  2004-05

2.  A quantitative analysis of kinase inhibitor selectivity.

Authors:  Mazen W Karaman; Sanna Herrgard; Daniel K Treiber; Paul Gallant; Corey E Atteridge; Brian T Campbell; Katrina W Chan; Pietro Ciceri; Mindy I Davis; Philip T Edeen; Raffaella Faraoni; Mark Floyd; Jeremy P Hunt; Daniel J Lockhart; Zdravko V Milanov; Michael J Morrison; Gabriel Pallares; Hitesh K Patel; Stephanie Pritchard; Lisa M Wodicka; Patrick P Zarrinkar
Journal:  Nat Biotechnol       Date:  2008-01       Impact factor: 54.908

Review 3.  Target profiling of small molecules by chemical proteomics.

Authors:  Uwe Rix; Giulio Superti-Furga
Journal:  Nat Chem Biol       Date:  2009-09       Impact factor: 15.040

4.  Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer.

Authors:  Eric B Haura; Tawee Tanvetyanon; Alberto Chiappori; Charles Williams; George Simon; Scott Antonia; Jhanelle Gray; Sharon Litschauer; Leticia Tetteh; Anthony Neuger; Lanxi Song; Bhupendra Rawal; Michael J Schell; Gerold Bepler
Journal:  J Clin Oncol       Date:  2010-02-08       Impact factor: 44.544

5.  Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection.

Authors:  Fei Huang; Karen Reeves; Xia Han; Craig Fairchild; Suso Platero; Tai W Wong; Francis Lee; Peter Shaw; Edwin Clark
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

6.  A chemical and phosphoproteomic characterization of dasatinib action in lung cancer.

Authors:  Jiannong Li; Uwe Rix; Bin Fang; Yun Bai; Arthur Edwards; Jacques Colinge; Keiryn L Bennett; Jingchun Gao; Lanxi Song; Steven Eschrich; Giulio Superti-Furga; John Koomen; Eric B Haura
Journal:  Nat Chem Biol       Date:  2010-02-28       Impact factor: 15.040

7.  Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.

Authors:  Martin L Sos; Kathrin Michel; Thomas Zander; Jonathan Weiss; Peter Frommolt; Martin Peifer; Danan Li; Roland Ullrich; Mirjam Koker; Florian Fischer; Takeshi Shimamura; Daniel Rauh; Craig Mermel; Stefanie Fischer; Isabel Stückrath; Stefanie Heynck; Rameen Beroukhim; William Lin; Wendy Winckler; Kinjal Shah; Thomas LaFramboise; Whei F Moriarty; Megan Hanna; Laura Tolosi; Jörg Rahnenführer; Roel Verhaak; Derek Chiang; Gad Getz; Martin Hellmich; Jürgen Wolf; Luc Girard; Michael Peyton; Barbara A Weir; Tzu-Hsiu Chen; Heidi Greulich; Jordi Barretina; Geoffrey I Shapiro; Levi A Garraway; Adi F Gazdar; John D Minna; Matthew Meyerson; Kwok-Kin Wong; Roman K Thomas
Journal:  J Clin Invest       Date:  2009-05-18       Impact factor: 14.808

8.  Cancer: A tumour gene's fatal flaws.

Authors:  Julian Downward
Journal:  Nature       Date:  2009-11-05       Impact factor: 49.962

9.  Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics.

Authors:  Cuiping Pan; Jesper V Olsen; Henrik Daub; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2009-08-03       Impact factor: 5.911

10.  The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib.

Authors:  Oliver Hantschel; Uwe Rix; Uwe Schmidt; Tilmann Bürckstümmer; Michael Kneidinger; Gregor Schütze; Jacques Colinge; Keiryn L Bennett; Wilfried Ellmeier; Peter Valent; Giulio Superti-Furga
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-07       Impact factor: 11.205
  10 in total
  3 in total

Review 1.  Endocrine side effects of broad-acting kinase inhibitors.

Authors:  Maya B Lodish; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2010-08-16       Impact factor: 5.678

Review 2.  Clinical review: kinase inhibitors: adverse effects related to the endocrine system.

Authors:  Maya B Lodish
Journal:  J Clin Endocrinol Metab       Date:  2013-02-28       Impact factor: 5.958

3.  Large-scale determination of absolute phosphorylation stoichiometries in human cells by motif-targeting quantitative proteomics.

Authors:  Chia-Feng Tsai; Yi-Ting Wang; Hsin-Yung Yen; Chih-Chiang Tsou; Wei-Chi Ku; Pei-Yi Lin; Hsuan-Yu Chen; Alexey I Nesvizhskii; Yasushi Ishihama; Yu-Ju Chen
Journal:  Nat Commun       Date:  2015-03-27       Impact factor: 14.919
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.